Predictors of Progressive Fibrosing Interstitial Lung Diseases and Survival in Fibrosing Interstitial Lung Disease-Related Usual Interstitial Pneumonia
Open Access
Abstract
Background and Objectives: Usual interstitial pneumonia (UIP) is associated with progressive fibrosing interstitial lung diseases (PF-ILD) and poor survival in patients with fibrosing interstitial lung disease (FILD). We aimed to investigate the predictors of PF-ILD and survival in patients with FILD-UIP. Materials and Methods: This retrospective study was conducted at a single, tertiary hospital in China. Patients underwent routine follow-up visits every 3 to 6 months according to standard operating procedures (SOPs). Patients with FILD-UIP were further stratified using the proposed PF-ILD criteria. Results: This retrospective study enrolled 150 patients with FILD-UIP between October 2020 and June 2025, with 117 patients completing follow-up for more than 12 months. FILD-UIP was categorized as idiopathic pulmonary fibrosis (IPF) (n = 67) and non-IPF-UIP (n = 50), which included connective tissue disease-associated UIP (n = 29), hypersensitivity pneumonitis-associated UIP (n = 7), and interstitial pneumonia with autoimmune features-associated UIP (n = 14). During the follow-up period, 32 (47.8%) patients with IPF and 19 (38.0%) non-IPF-UIP experienced PF-ILD. Pulmonary hypertension (PH) and predicted percentage of forced vital capacity (FVC%pred) were dependent risk factors for PF-ILD in patients with FILD-UIP, non-IPF-UIP, and IPF. King’s Brief Interstitial Lung Disease (KBILD) is a dependent risk factor for PF-ILD in patients with FILD-UIP and IPF. PF-ILD is similarly associated with poor survival in patients with FILD-UIP, non-IPF-UIP, and IPF. Conclusions: Baseline disease severity is closely associated with the incidence of PF-ILD, with all forms of FILD-UIP at risk of PF-ILD and showing similar outcomes to IPF-UIP/PF-ILD.Keywords
All Related Versions
Funding Information
- IIT Clinical Research Fund of The Second Affiliated Hospital of Xi’an Jiaotong University (IIT031)
- Multi-organism Precision Diagnosis and Treatment Engineering Research Center for Lung Diseases of Henan Province (DZXGCZXKF03)
- Natural Science Foundation of Shanxi Province, General Project-Surface Project (2024JC-YBMS-718)
This publication has 42 references indexed in Scilit:
- Usual interstitial pneumonia as a stand-alone diagnostic entity: the case for a paradigm shift?The Lancet Respiratory Medicine, 2023
- Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung DiseaseChest, 2022
- Defining and predicting progression in non-IPF interstitial lung diseaseRespiratory Medicine, 2021
- Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research prioritiesThe Lancet Respiratory Medicine, 2020
- The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI ApproachAdvances in Therapy, 2020
- Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary FibrosisChest, 2020
- Hypersensitivity PneumonitisChest, 2019
- Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patientsRespiratory Medicine, 2017
- Progressive Decline of Lung Function in Rheumatoid Arthritis–Associated Interstitial Lung DiseaseArthritis & Rheumatology, 2016
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975